Dr Eugene Maraskovsky

Dr Eugene Maraskovsky completed his PhD in Immunology at the Walter and Eliza Hall Institute in 1991. He was Senior Scientist and Project Leader working on cytokine discovery and translational research at the Immunex Corporation in Seattle.

He joined the Ludwig Institute for Cancer Research in 1998 as Joint Head of the Cancer Vaccine Laboratory. In 2002 he became a Principal Scientist and Group Leader at CSL Limited establishing a key capacity to measure immune responses in patients receiving ISCOMATRIX® vaccines. He is currently the Executive Director of CSL and Head of the Cell Biology and Physiology Division within CSL Research at the Bio21 Institute.

Dr Maraskovsky is also an Associate Professor at the University of Melbourne. He has over 110 primary publications (including 19 invited review articles on dendritic cells, vaccines, cancer and infectious disease) in international, peer-reviewed journals. He is a co-inventor on 29 patents and has presented on his research, as an invited speaker, at several international conferences and congresses.